GSK-Backed Sitryx Launches With Six Immunometabolism Eggs In Its Basket

 
• By Eleanor Malone

GlaxoSmithKline, SV Health Investors and Sofinnova are among the backers of a new Oxford-based biotech which has raised $30m in series A financing and boasts a strong line-up of academic founders. CEO Neil Weir outlines Sitryx's raison d'etre.

Wicker basket with six brown eggs. Isolated on white. Clipping path included.

More from Start-Ups & SMEs

More from Business